MWNA
GRTS

Marshall Wace North America’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Marshall Wace North America’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,329
Closed -$84K – 1700
2019
Q1 		$84K Buy
+6,329
New +$84.6K ﹤0.01% 1150
2018
Q4 		– Sell
-27,045
Closed -$385K – 1672
2018
Q3 		$385K Buy
+27,045
New +$385K ﹤0.01% 745

Other funds holding GRTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Marshall Wace North America's GRTS Position: Q2 2019 in Review

Marshall Wace North America sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2019, closing a stake of 6,329 shares — an estimated $84K sold.

Marshall Wace North America first reported a position in GRTS in Q3 2018 and held it in 2 quarters. The position peaked at $385K in Q3 2018. 63 funds tracked by Wall St. Rank hold GRTS as of Q2 2019.

  • Marshall Wace North America reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Marshall Wace North America sold 6,329 Gritstone bio, Inc. Common Stock shares in Q2 2019, an estimated $84K.
  • Marshall Wace North America first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 2 quarters.
  • Marshall Wace North America's Gritstone bio, Inc. Common Stock position peaked at $385K in Q3 2018.
  • 63 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2019.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.